We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (270)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (61)
- Manufacturing (51)
- Vaping hub (51)
- Labelling and packaging (34)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Import and export (24)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (4)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1245 result(s) found, displaying 1001 to 1025
-
Regulatory decision noticesNew requirements for listed medicines containing Andrographis paniculata
-
News articlesSome label warnings no longer required for medicines containing very low concentrations of menthol or methyl salicylate
-
Media releasesWe will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
News articlesGeneral information for consumers on prescription opioids
-
BlogFrom animals intestines to intrauterine devices, contraception has a fascinating history.
-
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
BlogBe informed and aware, but don’t be afraid.
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
BlogLearn about the evidence for medicinal cannabis, and how a medical doctor can organise medicinal cannabis access on behalf of appropriate patients.
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
BlogWhat does Neo from the Matrix need to know before choosing a pill to take?
-
Regulatory decision noticesTherapeutic Goods (Declared Goods) Order 2019 consolidates and replaces several instruments
-
Regulatory decision noticesJapan has recently been added to the list of Foreign Countries and Jurisdictions determined to be comparable overseas regulators
-
News articlesConsidering microneedling? Make sure you do your research first
-
BlogContamination has been discovered in some ranitidine products, but the immediate health risk is low.
-
BlogConsumer Medicine Information gives you the information you need to manage your health
-
Media releasesThe TGA has released the findings of its review into breast implants and breast tissue expanders
-
BlogFun facts about pirate medicine for Talk Like A Pirate Day